Unknown

Dataset Information

The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series.


ABSTRACT:

SUBMITTER: Yang T 

PROVIDER: S-EPMC11538723 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature